GAPDH and liver cancer: Inversely, Zhong et al. recently found that PRMT4 expression is decreased in malignant liver cancer and methylates GAPDH at R234 to repress glycolysis and proliferation of liver cancer cells, indicative of a tumor suppressor role 28.